Physician profile
Emerald Reeg
NPI 1245806140
$2,877.80
in general payments reported to CMS, 2019-2025
24 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $429 · 2022: $664 · 2023: $777 · 2024: $564 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,784.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $931.41 | 2022-2025 | Avvigo Guidance System, Rotapro, Rotablator Rotational Atherectomy System Console Kit |
| Amgen INC. | $389.50 | 2021-2023 | Repatha |
| Merck Sharp & Dohme LLC | $239.73 | 2021-2023 | Verquvo |
| Edwards Lifesciences Corporation | $201.66 | 2024 | |
| Amarin Pharma, INC. | $188.43 | 2021-2022 | |
| Shockwave Medical, INC | $157.76 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $145.32 | 2021-2023 | Farxiga |
| Pfizer INC. | $98.72 | 2022-2023 | |
| Abiomed | $97.30 | 2025 | |
| Kestra Medical Technology Services, INC. | $56.93 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $49.89 | 2022-2023 | Camzyos |
| Philips North America LLC | $46.15 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.45 | 2022-2023 | |
| Novo Nordisk INC | $32.42 | 2021-2023 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $32.23 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $27.23 | 2023 | |
| Asahi Intecc USA, INC. | $23.15 | 2023 | Asahi Ptca Guide Wire |
| Kiniksa Pharmaceuticals, LTD. | $20.13 | 2022 | |
| Astellas Pharma US INC | $19.44 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.69 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.71 | 2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.69 | 2023 | Jardiance |
| Amryt Pharma Holdings LTD | $16.15 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $12.71 | 2023 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emerald Reeg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.